Close

TG

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

TG acts as a substrate for the production of iodinated thyroid hormones thyroxine (T4) and triiodothyronine (T3) (PubMed:32025030, PubMed:17532758). The synthesis of T3 and T4 involves iodination of selected tyrosine residues of TG/thyroglobulin followed by their oxidative coupling in the thyroid follicle lumen (PubMed:32025030). Following TG re-internalization and lysosomal-mediated proteolysis, T3 and T4 are released from the polypeptide backbone leading to their secretion into the bloodstream (PubMed:32025030). One dimer produces 7 thyroid hormone molecules (PubMed:32025030).
  • CAR Vector Products

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAART-LX205 Anti-TG (2C7) h(CD28-CD3ζ) CAART, pCDCAAR1 Human 2C7 Human scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX206 Anti-TG (VB5) h(CD28-CD3ζ) CAART, pCDCAAR1 Human VB5 Human scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX207 Anti-TG (3C42) h(CD28-CD3ζ) CAART, pCDCAAR1 Human 3C42 Human scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX208 Anti-TG (J8B45.5) h(CD28-CD3ζ) CAART, pCDCAAR1 Human J8B45.5 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX209 Anti-TG (J8A32.13) h(CD28-CD3ζ) CAART, pCDCAAR1 Human J8A32.13 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX210 Anti-TG (MH52) h(CD28-CD3ζ) CAART, pCDCAAR1 Human MH52 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX211 Anti-TG (FI.1) h(CD28-CD3ζ) CAART, pCDCAAR1 Human FI.1 Human scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX212 Anti-TG (TI.1) h(CD28-CD3ζ) CAART, pCDCAAR1 Human TI.1 Human scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX213 Anti-TG (2C7) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human 2C7 Human scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX214 Anti-TG (VB5) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human VB5 Human scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX215 Anti-TG (3C42) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human 3C42 Human scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX216 Anti-TG (J8B45.5) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human J8B45.5 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX217 Anti-TG (J8A32.13) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human J8A32.13 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX218 Anti-TG (MH52) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human MH52 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX219 Anti-TG (FI.1) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human FI.1 Human scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX220 Anti-TG (TI.1) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human TI.1 Human scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.